Overexpression of miR-506-3p reversed doxorubicin resistance in drug-resistant osteosarcoma cells.
Wang X, Ding R, Fu Z, Yang M, Li D, Zhou Y, Qin C, Zhang W, Si L, Zhang J, Chai Y.
Wang X, et al. Among authors: zhang w, zhang j.
Front Pharmacol. 2024 Feb 14;15:1303732. doi: 10.3389/fphar.2024.1303732. eCollection 2024.
Front Pharmacol. 2024.
PMID: 38420199
Free PMC article.